Newton Biocapital is a venture capital firm in Belgium that focuses on financing biotech and life science projects. Founded 2017 in Brussels Hoofdstedelijk Gewest, Belgium by Alain Parthoens, it invests in early stage ventures and seed. Its portfolio companies include Acticor Biotech, EditForce, Sequana Medical, ChromaCure, Synergia Medical and DIM3. As of March 2020, Newton Biocapital has made seven investments. Their most recent investment was on November 6, 2019, when Acticor Biotech raised €7M. Newton Biocapital has had one exit, which was Sequana Medical. The company has raised a single venture fund, Newton Biocapital i S.A. Pricaf. This fund was announced on January 1, 2017 and raised a total of €82M.
Managing Partner and Founder
Documentaries, videos and podcasts